Compare Mahindra Manulife Mid Cap Fund vs Nippon India Growth Mid Cap Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.87
1.53
NAV
₹33.30
₹4180.50
Fund Started
08 Jan 2018
25 Sep 1995
Fund Size
₹4267.43 Cr
₹41727.36 Cr
Exit Load
Exit load of 1% if redeemed within 3 months.
Exit load of 1% if redeemed within 1 months
1 Year
14.36%
18.11%
3 Year
23.52%
24.91%
5 Year
19.63%
21.24%
Equity
97.90%
98.98%
Cash
2.10%
1.02%
Top 10 Holdings
Glenmark Pharmaceuticals Ltd. | 3.11% |
The Federal Bank Ltd. | 2.81% |
Piramal Finance Ltd. | 2.66% |
Union Bank of India | 2.63% |
Indusind Bank Ltd. | 2.57% |
Indus Towers Ltd. | 2.56% |
Max Financial Services Ltd. | 2.55% |
IDFC First Bank Ltd. | 2.49% |
AIA Engineering Ltd. | 2.48% |
Indian Bank | 2.43% |
BSE Ltd. | 3.42% |
The Federal Bank Ltd. | 2.83% |
Fortis Healthcare Ltd. | 2.76% |
AU Small Finance Bank Ltd. | 2.59% |
Persistent Systems Ltd. | 2.38% |
Voltas Ltd. | 2.20% |
Ashok Leyland Ltd. | 2.12% |
Cholamandalam Financial Holdings Ltd. | 2.12% |
Max Financial Services Ltd. | 1.97% |
Power Finance Corporation Ltd. | 1.92% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
The scheme aims at long term growth of capital through research based investment approach. The funds will be invested in Equity and equity related instruments ,and there will be an exposure to debt and money market instruments also.
Launch Date
08 Jan 2018
25 Sep 1995
